72.19.Z - Other research and experimental development on natural sciences and engineering
62.09.Z - Other information technology and computer service activities
63.99.Z - Other information service activities not elsewhere classified
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
70.22.Z - Business and other management consultancy activities
71.12.Z - Engineering activities and related technical consultancy
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 12,9 | 21,6 | 67,1 |
EBITDA | 13,6 | 21,8 | 60,7 |
Short time liabilities | 15,8 | 14,4 | -9,1 |
Equity capital | 44,4 | 67 | 50,9 |
Operating profit (EBIT) | 12,4 | 20,2 | 62,5 |
Assets | 78,5 | 99,8 | 27,1 |
Net profit (loss) | 14,1 | 21,5 | 52,9 |
Cash | 14,3 | 42,2 | 194,3 |
Net income from sale | 184,2 | 194,7 | 5,7 |
Liabilities and provisions for liabilities | 34,1 | 32,8 | -3,9 |
Working assets | 66 | 87,4 | 32,5 |
Depreciation | 1,1 | 1,6 | 41,3 |
% | % | p.p. | |
Profitability of capital | 31,7 | 32,1 | 0,4 |
Equity capital to total assets | 56,5 | 67,1 | 10,6 |
Gross profit margin | 7 | 11,1 | 4,1 |
EBITDA Margin | 7,4 | 11,2 | 3,8 |
Days | Days | Days | |
Short term commitment turnover cycle | 31 | 27 | -4 |
Current financial liquidity indicator | 4.160935878753662 | 5.921646595001221 | 1,7 |
Net dept to EBITDA | -1.052849531173706 | -1.9345402717590332 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane